- $195.01m
- $178.78m
- $54.72m
- 100
- 37
- 96
- 92
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 24.18 | ||
| PEG Ratio (f) | 1.28 | ||
| EPS Growth (f) | 23.23% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.47 | ||
| Price to Tang. Book | 4.54 | ||
| Price to Free Cashflow | 18.01 | ||
| Price to Sales | 3.27 | ||
| EV to EBITDA | 18.69 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 19.85% | ||
| Return on Equity | 16.11% | ||
| Operating Margin | 14.52% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 32.47 | 35.76 | 41.66 | 48.07 | 54.72 | 63.25 | 70.65 | 11.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +70.02 | -31.91 | -0.82 | +38.42 | +59.66 | +39.42 | +20.37 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Directors
- Kathleen Skarvan PRE (65)
- Michael MacCourt CFO (43)
- Stan Erickson IND (71)
- Gregory Fluet IND (52)
- Lee Jones IND (64)
- Andrea Walsh IND (58)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 16th, 1992
- Public Since
- August 13th, 2010
- No. of Shareholders
- 53
- No. of Employees
- 174
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NYSE MKT- Shares in Issue
- 8,556,844
- Address
- 500 6th Ave NW, NEW PRAGUE, 56071
- Web
- https://smartvest.com/
- Phone
- +1 9527589299
- Contact
- Mike Cavanaugh
- Auditors
- RSM US LLP
Upcoming Events for ELMD
Q4 2025 Electromed Inc Earnings Release
Similar to ELMD
Acme United
NYSE MKT
Alpha Pro Tech
NYSE MKT
Catheter Precision
NYSE MKT
Infusystem Holdings
NYSE MKT
Know Labs
NYSE MKT
FAQ
What is the Electromed share price?
As of Today at 20:24 UTC, shares in Electromed are trading at $22.79. This share price information is delayed by 15 minutes.
How has the Electromed share price performed this year?
Shares in Electromed last closed at $22.79 and the price had moved by +61.29% over the past 365 days. In terms of relative price strength the Electromed share price has outperformed the S&P500 Index by +51.66% over the past year.
What are the analyst and broker recommendations for Electromed?
The overall consensus recommendation for Electromed is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Electromed dividend yield?
Electromed does not currently pay a dividend.
Does Electromed pay a dividend?
Electromed does not currently pay a dividend.
When does Electromed next pay dividends?
Electromed does not currently pay a dividend.
How do I buy Electromed shares?
To buy shares in Electromed you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Electromed?
As of the previous close price of $22.79, shares in Electromed had a market capitalisation of $195.01m.
Where are Electromed shares listed?
Here are the trading details for Electromed:
- Country of listing: United States
- Exchange: ASQ
- Ticker Symbol: ELMD
What kind of share is Electromed?
Based on an overall assessment of its quality, value and momentum Electromed is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Electromed share price forecast for 2025?
The analyst consensus target price for shares in Electromed is $37.00. That is 62.35% above the last closing price of $22.79.
Analysts covering Electromed currently have a consensus Earnings Per Share (EPS) forecast of $0.81 for the next financial year.
Find out moreWhat is the trend in the Electromed share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Electromed. Over the past six months, its share price has outperformed the S&P500 Index by +9.42%.
As of the last closing price of $22.79, shares in Electromed were trading -4.05% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Electromed PE Ratio?
The Electromed PE ratio based on its reported earnings over the past 12 months is 24.18. The shares last closed at $22.79.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Electromed?
Electromed's management team is headed by:
- Kathleen Skarvan - PRE
- Michael MacCourt - CFO
- Stan Erickson - IND
- Gregory Fluet - IND
- Lee Jones - IND
- Andrea Walsh - IND